150 related articles for article (PubMed ID: 10901337)
21. The role of captodiamine in the withdrawal from long-term benzodiazepine treatment.
Mercier-Guyon C; Chabannes JP; Saviuc P
Curr Med Res Opin; 2004 Sep; 20(9):1347-55. PubMed ID: 15383182
[TBL] [Abstract][Full Text] [Related]
22. Severe withdrawal symptoms after discontinuation of alprazolam in eight patients with combat-induced posttraumatic stress disorder.
Risse SC; Whitters A; Burke J; Chen S; Scurfield RM; Raskind MA
J Clin Psychiatry; 1990 May; 51(5):206-9. PubMed ID: 2335496
[TBL] [Abstract][Full Text] [Related]
23. Impaired hypothalamic-pituitary-adrenocortical (HPA) system is related to severity of benzodiazepine withdrawal in patients with depression.
Wichniak A; Brunner H; Ising M; Pedrosa Gil F; Holsboer F; Friess E
Psychoneuroendocrinology; 2004 Oct; 29(9):1101-8. PubMed ID: 15219633
[TBL] [Abstract][Full Text] [Related]
24. Luteal phase treatment of premenstrual dysphoric disorder improves symptoms that continue into the postmenstrual phase.
Yonkers KA; Pearlstein T; Fayyad R; Gillespie JA
J Affect Disord; 2005 Apr; 85(3):317-21. PubMed ID: 15780701
[TBL] [Abstract][Full Text] [Related]
25. Discontinuation of benzodiazepine treatment: efficacy of cognitive-behavioral therapy for patients with panic disorder.
Otto MW; Pollack MH; Sachs GS; Reiter SR; Meltzer-Brody S; Rosenbaum JF
Am J Psychiatry; 1993 Oct; 150(10):1485-90. PubMed ID: 8379551
[TBL] [Abstract][Full Text] [Related]
26. Characteristics of placebo responses in medical treatment of premenstrual syndrome.
Freeman EW; Rickels K
Am J Psychiatry; 1999 Sep; 156(9):1403-8. PubMed ID: 10484952
[TBL] [Abstract][Full Text] [Related]
27. New concepts in benzodiazepine therapy: rebound anxiety and new indications for the more potent benzodiazepines.
Chouinard G; Labonte A; Fontaine R; Annable L
Prog Neuropsychopharmacol Biol Psychiatry; 1983; 7(4-6):669-73. PubMed ID: 6141609
[TBL] [Abstract][Full Text] [Related]
28. Mood and performance changes in women with premenstrual dysphoric disorder: acute effects of alprazolam.
Evans SM; Haney M; Levin FR; Foltin RW; Fischman MW
Neuropsychopharmacology; 1998 Dec; 19(6):499-516. PubMed ID: 9803426
[TBL] [Abstract][Full Text] [Related]
29. Double-blind comparison of alprazolam and diazepam for subchronic withdrawal from alcohol.
Kolin IS; Linet OI
J Clin Psychiatry; 1981 Apr; 42(4):169-73. PubMed ID: 7009593
[TBL] [Abstract][Full Text] [Related]
30. Diazepam versus alprazolam for the treatment of panic disorder.
Noyes R; Burrows GD; Reich JH; Judd FK; Garvey MJ; Norman TR; Cook BL; Marriott P
J Clin Psychiatry; 1996 Aug; 57(8):349-55. PubMed ID: 8752017
[TBL] [Abstract][Full Text] [Related]
31. Rebound anxiety in anxious patients after abrupt withdrawal of benzodiazepine treatment.
Fontaine R; Chouinard G; Annable L
Am J Psychiatry; 1984 Jul; 141(7):848-52. PubMed ID: 6145363
[TBL] [Abstract][Full Text] [Related]
32. Anxiolytic efficacy of alprazolam compared to diazepam and placebo.
Maletzky BM
J Int Med Res; 1980; 8(2):139-43. PubMed ID: 6102940
[TBL] [Abstract][Full Text] [Related]
33. Pregabalin for treatment of generalized anxiety disorder: a 4-week, multicenter, double-blind, placebo-controlled trial of pregabalin and alprazolam.
Rickels K; Pollack MH; Feltner DE; Lydiard RB; Zimbroff DL; Bielski RJ; Tobias K; Brock JD; Zornberg GL; Pande AC
Arch Gen Psychiatry; 2005 Sep; 62(9):1022-30. PubMed ID: 16143734
[TBL] [Abstract][Full Text] [Related]
34. Long-term therapeutic use of benzodiazepines. II. Effects of gradual taper.
Schweizer E; Rickels K; Case WG; Greenblatt DJ
Arch Gen Psychiatry; 1990 Oct; 47(10):908-15. PubMed ID: 2222130
[TBL] [Abstract][Full Text] [Related]
35. Withdrawal reaction after long-term therapeutic use of benzodiazepines.
Busto U; Sellers EM; Naranjo CA; Cappell H; Sanchez-Craig M; Sykora K
N Engl J Med; 1986 Oct; 315(14):854-9. PubMed ID: 3092053
[TBL] [Abstract][Full Text] [Related]
36. [Efficacy and withdrawal of clobazam, lorazepam and buspirone in the treatment of anxiety disorders].
Lemoine P; Rouillon F; Pouget D
Encephale; 1996; 22(6):461-7. PubMed ID: 10901839
[TBL] [Abstract][Full Text] [Related]
37. A controlled clinical trial of alprazolam for the treatment of anxiety.
Rickels K; Csanalosi I; Greisman P; Cohen D; Werblowsky J; Ross HA; Harris H
Am J Psychiatry; 1983 Jan; 140(1):82-5. PubMed ID: 6128927
[TBL] [Abstract][Full Text] [Related]
38. A controlled trial of ondansetron, a 5-HT3 antagonist, in benzodiazepine discontinuation.
Romach MK; Kaplan HL; Busto UE; Somer G; Sellers EM
J Clin Psychopharmacol; 1998 Apr; 18(2):121-31. PubMed ID: 9555597
[TBL] [Abstract][Full Text] [Related]
39. Effect of alprazolam and diazepam on anxiety and panic attacks in panic disorder: a controlled study.
Dunner DL; Ishiki D; Avery DH; Wilson LG; Hyde TS
J Clin Psychiatry; 1986 Sep; 47(9):458-60. PubMed ID: 2875064
[TBL] [Abstract][Full Text] [Related]
40. Alprazolam and diazepam in the treatment of generalized anxiety.
Elie R; Lamontagne Y
J Clin Psychopharmacol; 1984 Jun; 4(3):125-9. PubMed ID: 6145726
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
